CJS Securities downgraded Haemonetics (NYSE:HAE) from Market Outperform to Market Perform in a report released today.
- Updated: September 20, 2016
Yesterday Haemonetics (NYSE:HAE) traded 0.83% lower at $37.23. HAE’s 50-day moving average is $36.22 and its two hundred day moving average is $32.19. The last stock close is up 14.69% relative to the 200-day moving average, compared to the Standard & Poor’s 500 Index which has fallen -0.01% over the same period. Trading volume was was down over the average, with 97,757 shares of HAE changing hands under the typical 334,956 shares..
CJS Securities has downgraded Haemonetics(NYSE:HAE) from Market Outperform to Market Perform in a report released Tuesday September 20 2016.
See Chart Below:
In addition to CJS Securities reporting it’s target price, a total of 9 brokerages have issued a report on the stock. The one year target is $30.89 with three firms rating the company a strong buy, one analyst rating the company a buy, six analysts rating the stock a hold, two firms rating the stock to underperform, and finally 0 firms rating the company as sell.
Haemonetics has a 52 week low of $25.98 and a one-year high of $38.06 and has a market cap of $0.0.
Brief Synopsis About Haemonetics (NYSE:HAE)
Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company’s segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, and which include solutions for blood drive planning and blood collection.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.